Healthcare Services

Remote Irritable Bowel Syndrome (IBS) Monitoring Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Remote Irritable Bowel Syndrome (IBS) Monitoring Market Evolve From 2026 To 2030?

The remote irritable bowel syndrome (ibs) monitoring market size has expanded significantly in recent years. It is anticipated to increase from $1.4 billion in 2025 to $1.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. The expansion observed historically is attributable to the increasing incidence of irritable bowel syndrome, the development of digital health platforms, growing adoption of telehealth services, the wider application of smartphone-based health monitoring, and the accessibility of cloud-based patient data systems.

The remote irritable bowel syndrome (ibs) monitoring market is expected to experience substantial growth in the upcoming years. It is projected to achieve a size of $2.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.7%. This expansion during the forecast period is largely driven by the increasing need for individualized gastrointestinal care, the rising adoption of remote diagnostics, the broadening of value-based healthcare models, the growing application of predictive analytics in disease management, and increased investments in digital therapeutics. Significant trends anticipated during this period include a greater reliance on AI-driven symptom analytics, the increasing uptake of mobile health monitoring platforms, enhanced integration of wearable ibs tracking devices, the expansion of personalized treatment management tools, and an elevated focus on solutions for patient engagement.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29175&type=smp

What Major Drivers Are Influencing Demand In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

The expanding occurrence of gastrointestinal conditions is anticipated to drive the advancement of the remote irritable bowel syndrome (IBS) monitoring market in the future. These are illnesses that hinder the digestive system’s regular operation, disrupting digestion and bowel movements. This rise in gastrointestinal issues is primarily fueled by unhealthy eating patterns, which damage gut health and digestive processes, leading to inflammation and discomfort like bloating. Remote irritable bowel syndrome (IBS) monitoring assists in reducing the intensity of symptoms and delaying the progression of the condition through the early detection of triggers and continuous management, thereby enhancing patient results and overall quality of life. For example, in February 2025, Crohn’s & Colitis Australia, a national organization based in Australia, reported that the projected prevalence of inflammatory bowel disease (IBD) in Australia is forecast to grow from 20,511,881 cases in 2023 to 23,067,771 cases by 2030. Consequently, the increasing occurrence of gastrointestinal conditions is fueling the expansion of the remote irritable bowel syndrome (IBS) market.

Which Segment Areas Are Covered In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market Analysis?

The remote irritable bowel syndrome (ibs) monitoring market covered in this report is segmented –

1) By Component: Devices, Software, Services

2) By Application: Diagnosis, Symptom Tracking, Treatment Management, Patient Education, Other Applications

3) By End-User: Hospitals And Clinics, Homecare Settings, Research Institutes, Other End-Users

Subsegments:

1) By Devices: Wearable Monitoring Devices, Non-Wearable Monitoring Devices, Portable Monitoring Devices, Implantable Monitoring Devices

2) By Software: Data Analytics Software, Mobile Health Applications, Remote Monitoring Platforms, Cloud-Based Software Solutions

3) By Services: Teleconsultation Services, Data Management Services, Technical Support Services, Training And Education Services

How Are Trends Transforming The Remote Irritable Bowel Syndrome (IBS) Monitoring Market Landscape?

Leading companies in the remote irritable bowel syndrome (IBS) monitoring market are focusing on developing white-label or co-branded service models to leverage existing digital infrastructure and clinical support systems. This type of service model allows healthcare providers to deliver pre-designed digital health solutions under their own brand, merging a trusted identity with proven technology for quicker deployment, reduced costs, and a smooth patient experience. For instance, in May 2024, Salvo Health, a US-based digital gastrointestinal care company, unveiled its inaugural remote patient monitoring (RPM) enablement for gastrointestinal (GI) chronic conditions. The program presents a new digital care solution for conditions like IBS, GERD, dyspepsia, celiac disease, and SIBO, enabling GI practices to blend remote oversight with traditional in-person care. Salvo provides local GI providers with digital tools, clinical staff, and home monitoring devices via its white-label or co-branded model, allowing them to monitor heart rate variability (HRV) and link it with patient diet, behavior, and symptoms to enhance chronic care results and practice efficiency.

Which Global Companies Are Actively Competing In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

Major companies operating in the remote irritable bowel syndrome (ibs) monitoring market are Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., metaMe Health Inc., Seed Health, Ayble Health, Oshi health, Salvo Health Inc., modifyhealth Inc., Food marble, nerva health, MyGiHealth, Sun Genomics, Dietahealth, Dige Health, Nori health, Sequenex, Bowelle.

Read the full remote irritable bowel syndrome (ibs) monitoring market report here:

https://www.thebusinessresearchcompany.com/report/remote-irritable-bowel-syndrome-ibs-monitoring-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market?

North America was the largest region in the remote irritable bowel syndrome (IBS) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote irritable bowel syndrome (ibs) monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Remote Irritable Bowel Syndrome (IBS) Monitoring Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29175&type=smp

Browse Through More Reports Similar to the Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market 2026, By The Business Research Company

Remote Health Monitoring Global Market Report

https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report

Remote Surgery Global Market Report

https://www.thebusinessresearchcompany.com/report/remote-surgery-global-market-report

Artificial Intelligence Ai In Remote Patient Monitoring Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-remote-patient-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795